Intracranial Aneurysms Treatment With the OPTIMA Coil System
NCT ID: NCT03642821
Last Updated: 2025-09-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
300 participants
OBSERVATIONAL
2019-03-01
2023-02-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Optima Coil Performance in The Interventional Management of Intracranial Aneurysms Registry
NCT06282939
Appraising the Embolization of Aneurysms Using Balt Optima™ Coil System (APPLY Study)
NCT04499508
Study of the Penumbra Coil 400 System to Treat Aneurysm
NCT01465841
CLinical EValuation of WEB 0.017 Device in Intracranial AneuRysms
NCT03844334
Assessing the WAVE Extra Soft Coil in Intracranial Aneurysms and Comparing Imaging Modalities
NCT04106583
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
intracranial aneurysm coiling
endovascular treatment of intracranial aneurysm by coiling procedure using OPTIMA coils system
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. In case of multiple aneurysms, patient can be included when only 1 aneurysm is treated during the procedure and none of the other aneurysms are treated up to 30 days post-procedure
3. Patient older than 18 years
4. Patient who has been informed of the study and has signed an informed consent form where applicable according to local regulations.
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Balt Extrusion
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Innsbruck
Innsbruck, , Austria
CHU de Bordeaux - Hôpital Pellegrin
Bordeaux, , France
CHU de Brest - Hôpital La Cavale Blanche
Brest, , France
Hospices Civils de Lyon - Hôpital Neurologique
Bron, , France
CHU Côte de Nâcre
Caen, , France
Hôpital Privé Clairval
Marseille, , France
CHU Gui de Chaulliac
Montpellier, , France
CHU Hôpital Maison Blanche
Reims, , France
CHU Charles-Nicolle
Rouen, , France
CHRU Strasbourg Hautepierre
Strasbourg, , France
Zentralklinikum Augsburg
Augsburg, , Germany
Azienda Ospedallera
Catania, , Italy
San Gerardo Hospital
Monza, , Italy
Antonio Cardarelli Hospital
Napoli, , Italy
ULSS8 Berica Ospedale San Bortolo
Vicenza, , Italy
University of Latvia, Faculty of Medicine
Riga, , Latvia
Hospital Universitario de Burgos
Burgos, , Spain
Hospital: Fundacion Jimenez Diaz
Madrid, , Spain
Hospital: Puerta de Hierro
Madrid, , Spain
HUG Hôpital cantonal universitaire de geneva
Geneva, , Switzerland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CIP-201702-OPTIMA
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.